HC Wainwright & Co. Maintains Buy on Celldex Therapeutics, Raises Price Target to $54
HC Wainwright & Co. analyst Joseph Pantginis maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and raises the price target from $50 to $54.
Celldex Therapeutics Q2 EPS $(0.34) Up From $(0.50) YoY, Sales $3.48M Up From $236.00K YoY
Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.34) per share. This is a 32 percent increase over losses of $(0.50) per share from the same period last year. The company reported $3.48 million in
Stocks That Hit 52-Week Highs On Thursday
On Thursday morning, 159 companies achieved new highs for the year.
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 14)
10 Biggest Price Target Changes For Monday
RBC Capital boosted Chipotle Mexican Grill, Inc. (NYSE: CMG) price target from $1750 to $1800. Chipotle shares fell 0.1% to $1,590.09 in pre-market trading.
24 Stocks Moving in Monday’s Pre-Market Session
Gainers
SGOCO Group, Ltd. (NASDAQ: SGOC) shares rose 67.7% to $16.42 in pre-market trading after jumping around 280% on Friday.
Celldex Stock Surges As It Touts Early-Stage Skin Disease Study Win For CDX-0159
Celldex Therapeutics Inc (NASDAQ:CLDX) got a boost Friday with a data readout from Phase 1b trial of CDX-0159 in patients with…
HC Wainwright & Co. Maintains Buy on Celldex Therapeutics, Raises Price Target to $50
HC Wainwright & Co. analyst Joseph Pantginis maintains Celldex Therapeutics (NASDAQ:CLDX) with a Buy and raises the price target from $36 to $50.
The Daily Biotech Pulse: COVID Disappointments For Altimmune And Angion, Brickell Jumps On Hyperhidrosis Study Updates, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 29)